1
|
Toth R, Halmai M, Gyorfy Z, Balint E, Unk I. The inner side of yeast PCNA contributes to genome stability by mediating interactions with Rad18 and the replicative DNA polymerase δ. Sci Rep 2022; 12:5163. [PMID: 35338218 PMCID: PMC8956578 DOI: 10.1038/s41598-022-09208-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Accepted: 03/14/2022] [Indexed: 11/09/2022] Open
Abstract
PCNA is a central orchestrator of cellular processes linked to DNA metabolism. It is a binding platform for a plethora of proteins and coordinates and regulates the activity of several pathways. The outer side of PCNA comprises most of the known interacting and regulatory surfaces, whereas the residues at the inner side constitute the sliding surface facing the DNA double helix. Here, by investigating the L154A mutation found at the inner side, we show that the inner surface mediates protein interactions essential for genome stability. It forms part of the binding site of Rad18, a key regulator of DNA damage tolerance, and is required for PCNA sumoylation which prevents unscheduled recombination during replication. In addition, the L154 residue is necessary for stable complex formation between PCNA and the replicative DNA polymerase δ. Hence, its absence increases the mutation burden of yeast cells due to faulty replication. In summary, the essential role of the L154 of PCNA in guarding and maintaining stable replication and promoting DNA damage tolerance reveals a new connection between these processes and assigns a new coordinating function to the central channel of PCNA.
Collapse
Affiliation(s)
- Robert Toth
- The Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged, 6726, Hungary
| | - Miklos Halmai
- The Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged, 6726, Hungary
| | - Zsuzsanna Gyorfy
- The Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged, 6726, Hungary
| | - Eva Balint
- The Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged, 6726, Hungary
| | - Ildiko Unk
- The Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged, 6726, Hungary.
| |
Collapse
|
2
|
Toth R, Balogh D, Pinter L, Jaksa G, Szeplaki B, Graf A, Gyorfy Z, Enyedi MZ, Kiss E, Haracska L, Unk I. The Rad5 Helicase and RING Domains Contribute to Genome Stability through their Independent Catalytic Activities. J Mol Biol 2022; 434:167437. [PMID: 34990655 DOI: 10.1016/j.jmb.2021.167437] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 12/08/2021] [Accepted: 12/28/2021] [Indexed: 11/27/2022]
Abstract
Genomic stability is compromised by DNA damage that obstructs replication. Rad5 plays a prominent role in DNA damage bypass processes that evolved to ensure the continuation of stalled replication. Like its human orthologs, the HLTF and SHPRH tumor suppressors, yeast Rad5 has a RING domain that supports ubiquitin ligase activity promoting PCNA polyubiquitylation and a helicase domain that in the case of HLTF and Rad5 was shown to exhibit an ATPase-linked replication fork reversal activity. The RING domain is embedded in the helicase domain, confusing their separate investigation and the understanding of the exact role of Rad5 in DNA damage bypass. Particularly, it is still debated whether the helicase domain plays a catalytic or a non-enzymatic role during error-free damage bypass and whether it facilitates a function separately from the RING domain. In this study, through in vivo and in vitro characterization of domain-specific mutants, we delineate the contributions of the two domains to Rad5 function. Yeast genetic experiments and whole-genome sequencing complemented with biochemical assays demonstrate that the ubiquitin ligase and the ATPase-linked activities of Rad5 exhibit independent catalytic activities in facilitating separate pathways during error-free lesion bypass. Our results also provide important insights into the mutagenic role of Rad5 and indicate its tripartite contribution to DNA damage tolerance.
Collapse
Affiliation(s)
- Robert Toth
- DNA Repair Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary; University of Szeged, Doctoral School of Biology, Hungary
| | - David Balogh
- HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary
| | | | | | | | - Alexandra Graf
- HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary
| | - Zsuzsanna Gyorfy
- DNA Repair Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary
| | - Marton Zs Enyedi
- HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary; Delta Bio 2000 Ltd., Szeged H-6726, Hungary
| | - Erno Kiss
- HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary
| | - Lajos Haracska
- HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary
| | - Ildiko Unk
- DNA Repair Research Group, Institute of Genetics, Biological Research Centre, Szeged, Eotvos Loránd Research Network, Szeged H-6726, Hungary.
| |
Collapse
|
3
|
Venclicek O, Skrickova J, Brat K, Fischer O, Havel L, Hrnciarik M, Marel M, Opalka P, Krakorova G, Rozsivalova D, Kultan J, Mullerova A, Zarnayova L, Smickova P, Vasakova M, Gyorfy Z, Jirousek M, Krejci D, Krejci J, Zuna P, Svaton M, Hrda K, Duba J, Alahakoon J, Svoboda M, Silar J. Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry. Anticancer Res 2021; 41:5549-5556. [PMID: 34732425 DOI: 10.21873/anticanres.15368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 10/15/2021] [Accepted: 10/18/2021] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018. The aim of the study was to assess the stage of the disease at the time of diagnosis, percentage of morphological types, survival, percentage of driving mutations, eligibility for radical surgery, and percentage of patients who undergo radical surgery, in the non-smoking population in comparison with smokers and former smokers. PATIENTS AND METHODS The total number of patients in the registry at the time of the analysis was 2,743. Only 2,439 patients with complete records (smoking status, stage, and type of tumor) were included in this study. RESULTS The analysis indicated that non-smokers are diagnosed at a later stage of the disease but they have a better survival rate than smokers. Fewer smokers with stage III disease who are eligible for radical surgery will undergo surgery compared to non-smokers with the same clinical stage. Driving mutations are more common in non-smokers, even after adjustment for the more frequent occurrence of adenocarcinoma in the group of non-smokers. CONCLUSION The data from LUCAS registry are consistent with already known facts, suggesting that the LUCAS registry is a useful clinical tool.
Collapse
Affiliation(s)
- Ondrej Venclicek
- Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic; .,Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - Jana Skrickova
- Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic.,Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - Kristian Brat
- Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic.,Faculty of Medicine, Masaryk University, Brno, Czech Republic.,International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
| | - Ondrej Fischer
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Libor Havel
- Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.,1 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Michal Hrnciarik
- Pulmonary Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.,Charles University, Faculty of Medicine, Hradec Kralove, Czech Republic
| | - Miloslav Marel
- Department of Pulmonology, University Hospital Motol, Prague, Czech Republic.,2 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Petr Opalka
- Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic.,3 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Gabriela Krakorova
- Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic.,3 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Denisa Rozsivalova
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Juraj Kultan
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Andrea Mullerova
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Lydia Zarnayova
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Petra Smickova
- Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.,Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Martina Vasakova
- Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.,1 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Zsuzsanna Gyorfy
- Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.,1 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Michal Jirousek
- Pulmonary Department, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.,Charles University, Faculty of Medicine, Hradec Kralove, Czech Republic
| | - Daniel Krejci
- Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic.,3 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Jana Krejci
- Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic.,3 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Petr Zuna
- Department of Pneumology, Bulovka University Hospital, Prague, Czech Republic.,3 Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Martin Svaton
- Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic.,Faculty of Μedicine in Pilsen, Charles University, Pilsen, Czech Republic
| | - Kristyna Hrda
- Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic.,Faculty of Μedicine in Pilsen, Charles University, Pilsen, Czech Republic
| | | | | | - Michal Svoboda
- Faculty of Medicine, Masaryk University, Brno, Czech Republic.,Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
| | - Jiri Silar
- Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
| |
Collapse
|
4
|
Frittmann O, Gali VK, Halmai M, Toth R, Gyorfy Z, Balint E, Unk I. The Zn-finger of Saccharomyces cerevisiae Rad18 and its adjacent region mediate interaction with Rad5. G3 (Bethesda) 2021; 11:6133228. [PMID: 33570581 PMCID: PMC8759821 DOI: 10.1093/g3journal/jkab041] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Indexed: 11/13/2022]
Abstract
DNA damages that hinder the movement of the replication complex can ultimately lead to cell death. To avoid that, cells possess several DNA damage bypass mechanisms. The Rad18 ubiquitin ligase controls error-free and mutagenic pathways that help the replication complex to bypass DNA lesions by monoubiquitylating PCNA at stalled replication forks. In Saccharomyces cerevisiae, two of the Rad18 governed pathways are activated by monoubiquitylated PCNA and they involve translesion synthesis polymerases, whereas a third pathway needs subsequent polyubiquitylation of the same PCNA residue by another ubiquitin ligase the Rad5 protein, and it employs template switching. The goal of this study was to dissect the regulatory role of the multidomain Rad18 in DNA damage bypass using a structure-function based approach. Investigating deletion and point mutant RAD18 variants in yeast genetic and yeast two-hybrid assays we show that the Zn-finger of Rad18 mediates its interaction with Rad5, and the N-terminal adjacent region is also necessary for Rad5 binding. Moreover, results of the yeast two-hybrid and in vivo ubiquitylation experiments raise the possibility that direct interaction between Rad18 and Rad5 might not be necessary for the function of the Rad5 dependent pathway. The presented data also reveal that yeast Rad18 uses different domains to mediate its association with itself and with Rad5. Our results contribute to better understanding of the complex machinery of DNA damage bypass pathways.
Collapse
Affiliation(s)
- Orsolya Frittmann
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary.,Doctoral School of Biology, University of Szeged, Szeged, H-6720, Hungary
| | - Vamsi K Gali
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| | - Miklos Halmai
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| | - Robert Toth
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| | - Zsuzsanna Gyorfy
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| | - Eva Balint
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| | - Ildiko Unk
- Biological Research Centre, Szeged, Eotvos Loránd Research Network, The Institute of Genetics, Szeged, H-6726, Hungary
| |
Collapse
|
6
|
Gyorfy Z, Draskovits G, Vernyik V, Blattner FF, Gaal T, Posfai G. Engineered ribosomal RNA operon copy-number variants of E. coli reveal the evolutionary trade-offs shaping rRNA operon number. Nucleic Acids Res 2015; 43:1783-94. [PMID: 25618851 PMCID: PMC4330394 DOI: 10.1093/nar/gkv040] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Ribosomal RNA (rrn) operons, characteristically present in several copies in bacterial genomes (7 in E. coli), play a central role in cellular physiology. We investigated the factors determining the optimal number of rrn operons in E. coli by constructing isogenic variants with 5–10 operons. We found that the total RNA and protein content, as well as the size of the cells reflected the number of rrn operons. While growth parameters showed only minor differences, competition experiments revealed a clear pattern: 7–8 copies were optimal under conditions of fluctuating, occasionally rich nutrient influx and lower numbers were favored in stable, nutrient-limited environments. We found that the advantages of quick adjustment to nutrient availability, rapid growth and economic regulation of ribosome number all contribute to the selection of the optimal rrn operon number. Our results suggest that the wt rrn operon number of E. coli reflects the natural, ‘feast and famine’ life-style of the bacterium, however, different copy numbers might be beneficial under different environmental conditions. Understanding the impact of the copy number of rrn operons on the fitness of the cell is an important step towards the creation of functional and robust genomes, the ultimate goal of synthetic biology.
Collapse
Affiliation(s)
- Zsuzsanna Gyorfy
- Institute of Biochemistry, Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged 6726, Hungary
| | - Gabor Draskovits
- Institute of Biochemistry, Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged 6726, Hungary
| | - Viktor Vernyik
- Institute of Biochemistry, Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged 6726, Hungary
| | | | - Tamas Gaal
- Dept. of Bacteriology, Univ. of Wisconsin-Madison, Madison, WI 53706, USA
| | - Gyorgy Posfai
- Institute of Biochemistry, Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged 6726, Hungary
| |
Collapse
|